Terms ending in 2035
Every in-force patent on Pfizer Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,492,559 | Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 10,105,431 | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 10,918,708 | Streptococcus Pneumoniae Capsular Polysaccharides and Conjugates Thereof In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 11,090,375 | Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 11,160,855 | Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 11,426,456 | Streptococcus Pneumoniae Capsular Polysaccharides and Conjugates Thereof In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 12,616,744 | Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof In force · Low confidence | Pfizer Inc. | In force | Low confidence | |
| US 10,086,085 | Bifunctional Cytotoxic Agents In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 10,391,182 | Bifunctional Cytotoxic Agents In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 10,570,202 | Combination of a PD-1 Antagonist and a Vegfr Inhibitor for Treating Cancer In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| 74 more term ends in 2035 · Pro | |||||
10 of 84 patents shown. Soonest term end first, then patent number.
Pro members see all 84.
73 of these are in force and held by Pfizer Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.